研究者業績

堀口 明彦

ホリグチ アキヒコ  (Akihiko Horiguchi)

基本情報

所属
藤田医科大学ばんたね病院 医学部 消化器外科学 病院長・教授
学位
医学博士(1901年3月 藤田保健衛生大学大学院)

J-GLOBAL ID
200901021819103327
researchmap会員ID
1000170789

外部リンク

論文

 466
  • Mina Ikeda, Hiroyuki Kato, Satoshi Arakawa, Takashi Kobayashi, Senju Hashimoto, Yoshiaki Katano, Ken-Ichi Inada, Yuka Kiriyama, Takuma Ishihara, Satoshi Yamamoto, Yukio Asano, Akihiko Horiguchi
    Pathology international 2024年9月11日  
    This study aimed to validate the DFS (direct fast scarlet) staining in the diagnosis of EC (eosinophilic colitis). The study included 50 patients with EC and 60 with control colons. Among the 60 control samples, 39 and 21 were collected from the ascending and descending colons, respectively. We compared the median number of eosinophils and frequency of eosinophil degranulation by HE (hematoxylin and eosin) and DFS staining between the EC and control groups. In the right hemi-colon, eosinophil count by HE was useful in distinguishing between EC and control (41.5 vs. 26.0 cells/HPF, p < 0.001), but the ideal cutoff value is 27.5 cells/HPF (high-power field). However, this method is not useful in the left hemi-colon (12.5 vs. 13.0 cells/HPF, p = 0.990). The presence of degranulation by DFS allows us to distinguish between the groups even in the left hemi-colon (58% vs. 5%, p < 0.001). DFS staining also enabled a more accurate determination of degranulation than HE. According to the current standard to diagnose EC (count by HE staining ≥20 cells/HPF), mucosal sampling from left hemi-colon is problematic since the number of eosinophils could not be increased even in EC. Determination of degranulated eosinophils by DFS may potentiate the diagnostic performance even in such conditions.
  • Seiko Hirono, Ryota Higuchi, Goro Honda, Satoshi Nara, Minoru Esaki, Naoto Gotohda, Hideki Takami, Michiaki Unno, Teiichi Sugiura, Masayuki Ohtsuka, Yasuhiro Shimizu, Ippei Matsumoto, Toshifumi Kin, Hiroyuki Isayama, Daisuke Hashimoto, Yasuji Seyama, Hiroaki Nagano, Kenichi Hakamada, Satoshi Hirano, Yuichi Nagakawa, Shugo Mizuno, Hidenori Takahashi, Kazuto Shibuya, Hideki Sasanuma, Taku Aoki, Yuichiro Kohara, Toshiki Rikiyama, Masafumi Nakamura, Itaru Endo, Yoshihiro Sakamoto, Akihiko Horiguchi, Takashi Hatori, Hirofumi Akita, Toshiharu Ueki, Tetsuya Idichi, Keiji Hanada, Shuji Suzuki, Keiichi Okano, Hiromitsu Maehira, Fuyuhiko Motoi, Yasuhiro Fujino, Satoshi Tanno, Akio Yanagisawa, Yoshifumi Takeyama, Kazuichi Okazaki, Sohei Satoi, Hiroki Yamaue
    Annals of gastroenterological surgery 8(5) 845-859 2024年9月  
    BACKGROUND: Surgical resection is standard treatment for invasive intraductal papillary mucinous carcinoma (IPMC); however, impact of multidisciplinary treatment on survival including postoperative adjuvant therapy (AT), neoadjuvant therapy (NAT), and treatment for recurrent lesions is unclear. We investigated the effectiveness of multidisciplinary treatment in prolonging survival of patients with invasive IPMC. METHODS: This retrospective multi-institutional study included 1183 patients with invasive IPMC undergoing surgery at 40 academic institutions. We analyzed the effects of AT, NAT, and treatment for recurrence on survival of patients with invasive IPMC. RESULTS: Completion of the planned postoperative AT for 6 months improved the overall survival (OS), disease-specific survival (DSS), and recurrence-free survival (RFS) of patients with stage IIB and stage III resected invasive IPMC, elevated preoperative carbohydrate antigen 19-9 level, lymphovascular invasion, perineural invasion, serosal invasion, and lymph node metastasis on un-matched and matched analyses. Of the patients with borderline resectable (BR) invasive IPMC, the OS (p = 0.001), DSS (p = 0.001), and RFS (p = 0.001) of patients undergoing NAT was longer than that of those without on the matched analysis. Of the 484 invasive IPMC patients (40.9%) who developed recurrence after surgery, the OS of 365 patients who received any treatment for recurrence was longer than that of those without treatment (40.6 vs. 22.4 months, p < 0.001). CONCLUSION: Postoperative AT might benefit selected patients with invasive IPMC, especially those at high risk of poor survival. NAT might improve the survivability of BR invasive IPMC. Any treatment for recurrence after surgery for invasive IPMC might improve survival.
  • Masahiro Shimura, Hiroyuki Kato, Yukio Asano, Hidetoshi Nagata, Yuka Kondo, Satoshi Arakawa, Daisuke Koike, Takayuki Ochi, Hironobu Yasuoka, Toki Kawai, Takahiko Higashiguchi, Hiroki Tani, Yoshiki Kunimura, Kazuma Horiguchi, Yutaro Kato, Masahiro Ito, Tsunekazu Hanai, Akihiko Horiguchi
    Fujita medical journal 10(3) 69-74 2024年8月  
    OBJECTIVE: This study was performed to demonstrate the clinical application of duodenum-preserving pancreatic head resection (DPPHR) as a surgical treatment for pancreatic neuroendocrine tumors (PNETs) in terms of both curability and maintenance of postoperative quality of life. METHODS: Seven patients diagnosed with PNETs underwent DPPHR from January 2011 to December 2021 at our institution. We investigated the clinical relevance of DPPHR based on the patients' clinicopathological findings. RESULTS: The median operative time was 492 min, and the median blood loss was 302 g. Postoperative complications were evaluated according to the Clavien-Dindo classification, and postoperative intra-abdominal bleeding was observed in one patient. Pathological examination revealed a World Health Organization classification of G1 in six patients and G2 in one patient. Microvascular invasion was observed in two patients (29%); however, no patients developed lymph node metastasis or recurrence during the follow-up period. A daughter lesion was observed near the primary tumor in one patient. All patients achieved curative resection, and no tumor specimens showed positive margins. CONCLUSIONS: DPPHR facilitates anatomical resection of the pancreatic head in patients with PNETs as well as detailed pathological evaluation of the resected specimen. Therefore, this surgical procedure is an acceptable alternative to pancreaticoduodenectomy or enucleation for patients with PNETs.
  • Susumu Hijioka, Daiki Yamashige, Minoru Esaki, Goro Honda, Ryota Higuchi, Toshihiko Masui, Yasuhiro Shimizu, Masayuki Ohtsuka, Yusuke Kumamoto, Akio Katanuma, Naoto Gotohda, Hirofumi Akita, Michiaki Unno, Itaru Endo, Yukihiro Yokoyama, Suguru Yamada, Ippei Matsumoto, Takao Ohtsuka, Satoshi Hirano, Hiroaki Yasuda, Manabu Kawai, Taku Aoki, Masafumi Nakamura, Daisuke Hashimoto, Toshiki Rikiyama, Akihiko Horiguchi, Tsutomu Fujii, Shugo Mizuno, Keiji Hanada, Masaji Tani, Takashi Hatori, Tetsuhide Ito, Masataka Okuno, Shingo Kagawa, Hiroshi Tajima, Tatsuya Ishii, Motokazu Sugimoto, Shunsuke Onoe, Hideki Takami, Ryoji Takada, Takayuki Miura, Yusuke Kurita, Keiko Kamei, Yuko Mataki, Kazuichi Okazaki, Yoshifumi Takeyama, Hiroki Yamaue, Sohei Satoi
    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 22(7) 1416-1426 2024年7月  
    BACKGROUND & AIMS: Despite previously reported treatment strategies for nonfunctioning small (≤20 mm) pancreatic neuroendocrine neoplasms (pNENs), uncertainties persist. We aimed to evaluate the surgically resected cases of nonfunctioning small pNENs (NF-spNENs) in a large Japanese cohort to elucidate an optimal treatment strategy for NF-spNENs. METHODS: In this Japanese multicenter study, data were retrospectively collected from patients who underwent pancreatectomy between January 1996 and December 2019, were pathologically diagnosed with pNEN, and were treated according to the World Health Organization 2019 classification. Overall, 1490 patients met the eligibility criteria, and 1014 were included in the analysis cohort. RESULTS: In the analysis cohort, 606 patients (59.8%) had NF-spNENs, with 82% classified as grade 1 (NET-G1) and 18% as grade 2 (NET-G2) or higher. The incidence of lymph node metastasis (N1) by grade was significantly higher in NET-G2 (G1: 3.1% vs G2: 15.0%). Independent factors contributing to N1 were NET-G2 or higher and tumor diameter ≥15 mm. The predictive ability of tumor size for N1 was high. Independent factors contributing to recurrence included multiple lesions, NET-G2 or higher, tumor diameter ≥15 mm, and N1. However, the independent factor contributing to survival was tumor grade (NET-G2 or higher). The appropriate timing for surgical resection of NET-G1 and NET-G2 or higher was when tumors were >20 and >10 mm, respectively. For neoplasms with unknown preoperative grades, tumor size >15 mm was considered appropriate. CONCLUSIONS: NF-spNENs are heterogeneous with varying levels of malignancy. Therefore, treatment strategies based on tumor size alone can be unreliable; personalized treatment strategies that consider tumor grading are preferable.
  • Makoto Ueno, Sachiyo Shirakawa, Jumpei Tokumaru, Mizue Ogi, Kenichiro Nishida, Takehiro Hirai, Kenta Shinozaki, Yoko Hamada, Hiroshi Kitagawa, Akihiko Horiguchi
    Journal of hepato-biliary-pancreatic sciences 31(7) 468-480 2024年7月  
    PURPOSE: To describe the real-world treatment patterns of systemic therapies for biliary tract cancer (BTC) and to examine the frequency and management of biliary infection in Japan. METHODS: Patients diagnosed with BTC and prescribed systemic therapy between January 2011 and September 2020 were retrieved from the Japanese Medical Data Vision database. The look-back period was set to 5 years. Patient characteristics, treatment patterns, and biliary infection-induced treatment interruption were analyzed. RESULTS: The full analysis set comprised 22 742 patients with a mean age of 71.0 years and 61.6% were male. The most common BTC type was extrahepatic cholangiocarcinoma (44.6%). The three most common first-line regimens were S-1 monotherapy (33.0%), gemcitabine+cisplatin (32.5%), and gemcitabine monotherapy (18.7%) over the entire observation period (January 2011-September 2021). Patients who received monotherapies tended to be older. Biliary infection-induced treatment interruption occurred in 29.5% of patients, with a median time to onset of 64.0 (interquartile range 29.0-145.0) days. The median duration of intravenous antibiotics was 12.0 (interquartile range 4.0-92.0) days. CONCLUSIONS: These results demonstrated potential challenges of BTC in Japanese clinical practice particularly use of multiple regimens, commonly monotherapies, which are not recommended as first-line treatment, and the management of biliary infections during systemic therapy.

MISC

 940
  • 山元 俊行, 堀口 明彦, 石原 慎, 伊東 昌広, 浅野 之夫, 古澤 浩一, 津田 一樹, 伊藤 良太郎, 森垣 曉子, 山田 智洋, 宮川 秀一
    日本臨床外科学会雑誌 72(5) 1325-1325 2011年5月  
  • 石原 慎, 宮川 秀一, 堀口 明彦, 宮崎 勝, 高田 忠敬
    胆と膵 32(5) 379-383 2011年5月  
    開腹胆嚢摘出術および胆嚢癌症例におけるIncidental gallbladder cancerの頻度とその特徴について報告する。開腹胆嚢摘出術に占めるIncidental gallbladder cancerの頻度は、0.23%〜3.86%であった。報告例の集計では、開腹胆嚢摘出術を施行された14,731例中113例(0.77%)に認められ、腹腔鏡下胆嚢摘出術では、45,174例中294例(0.65%)であり、術式によりIncidental gallbladder cancerの頻度に差を認めなかった。本邦の胆嚢癌症例におけるIncidental gallbladder cancerの頻度は13.4%であり、既報告の20.8%〜65.8%より低かった。術前診断は胆嚢結石およびその併存疾患が346例(57.6%)と最多であった。腫瘍の肉眼的形態は平坦浸潤型が最多であった。組織学的検討では、胆嚢周囲進展度の低いもの、リンパ節転移のないもの、Stageが低いものが多く、1年、3年、5年生存率は、それぞれ82.8%、65.7%、59.2%であり、Nonincidental gallbladder cancerに比較し有意に予後良好であった。(著者抄録)
  • 堀口 明彦, 宇山 一朗, 伊東 昌広, 石原 慎, 浅野 之夫, 古澤 浩一, 山元 俊行, 宮川 秀一
    日本外科学会雑誌 112(臨増1-2) 255-255 2011年5月  
  • 山田 智洋, 堀口 明彦, 伊東 昌広, 山元 俊行, 伊藤 良太郎, 宮川 秀一
    日本外科学会雑誌 112(臨増1-2) 678-678 2011年5月  
  • 石原 慎, 宮川秀一, 堀口明彦, 宮崎 勝, 高田忠敬
    胆と膵 32(5) 379-383 2011年5月  
  • Akihiko Horiguchi, Shin Ishihara, Masahiro Ito, Yukio Asano, Koichi Furusawa, Toshiyuki Yamamoto, Shuichi Miyakawa
    HEPATO-GASTROENTEROLOGY 58(107) 1018-1021 2011年5月  査読有り
    Background/Aims: Intraductal papillary mucinous neoplasm (IPMN) and pancreatic endocrine tumors can develop at multiple sites of the pancreas at the same time, sometimes necessitating total pancreatectomy. When low-grade pancreatic malignancy is treated surgically, preservation of function to improve long-term QOL is emphasized. For low grade malignancy tumor of the pancreatic head and tail, we performed middle- segment-preserving pancreatectomy (MSPP), with resection of the pancreatic head and tail alone, resulting in favorable QOL. Methodology: MSPP was performed for 4 patients. Intraoperative blood loss, hospital stay, postoperative complications, histopathological findings and prognosis were examined. Results: Mean intraoperative blood loss was 1255 +/- 365g, mean hospital stay 61 +/- 53 days, and mortality 0%. Postoperatively, pancreatic fistula was observed in 3 patients, but subsided with conservative treatment. In one patient with diabetes preoperatively, diabetes was exacerbated postoperatively, necessitating insulin treatment. No postoperative onset of diabetes was observed. Percent change in body weight during the postoperative 6 month period from preoperative weight was 93 +/- 6.3%. One patient died of malignant lymphoma 1 year and 4 months after surgery. The other patients are alive and socially active. Conclusion: MSPP enables maintenance of good QOL long after surgery for malignancy affecting the head and tail of the pancreas.
  • 堀口明彦, 石原 慎, 伊東昌広, 浅野之夫, 山元俊行, 宮川秀一
    日本外科学会雑誌 112(3) 159-163 2011年3月  
  • A. Horiguchi, I. Uyama, S. Miyakawa
    JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES 18(2) 287-291 2011年3月  
    Robotic surgery is the most advanced development in minimally invasive surgery. However, the number of reports on robot-assisted endoscopic gastrointestinal surgery is still very small. In this article, we describe total laparoscopic pancreaticoduodenectomy (PD) undertaken using the da Vinci Surgical SystemA (R) (Intutive Surgical). Three patients underwent robotic PD between November 2009 and February 2010. Following resection of the pancreatic head, duodenum, and the distal stomach, intracorporeal anastomosis was accomplished by Child&apos;s method of reconstruction, which includes a two-layered end-to-side pancreaticojejunostomy, an end-to-side choledochojejunostomy, and a side-to-side gastrojejunostomy. The time required for surgery was 703 +/- A 141 min, and blood loss was 118 +/- A 72 mL. The average hospital stay period was 26 +/- A 12 days. As a postoperative complication, pancreatic juice leak occurred in one case, but it was managed with conservative treatment. Of the three patients, one had cancer of the papilla of Vater, one had cancer of the pancreatic head, and one had a solid pseudopapillary neoplasm. In all cases, the surgical margin was negative for tumor. Robot-assisted PD required a long time, but organ removal with less bleeding was able to be safely performed owing to the high degree of freedom associated with the forceps manipulation and the magnified view. Similarly, pancreatojejunostomy could certainly be conducted. No major postoperative complications were found. Accumulation of da Vinci PD experience in the future will lead to safer and faster PD.
  • 伊東 昌広, 堀口 明彦, 宮川 秀一
    手術 65(2) 195-198 2011年2月  
  • 伊東 昌広, 堀口 明彦, 宮川 秀一
    手術 65(2) 195-198 2011年2月  
  • 宮川 秀一, 堀口 明彦, 石原 慎, 伊東 昌広, 浅野 之夫, 古澤 浩一, 清水 朋宏, 山元 俊行, 伊藤 良太郎, 津田 一樹, 森垣 暁子, 山田 智洋
    外科治療 104(2) 177-181 2011年2月  
    膵頭前後面の動脈アーケードの血管走行にはその発達程度に差があり、また胆管と膵実質への埋没形態も一定でないことはすでに報告されている。十二指腸温存膵頭切除に胆管の温存も併置する術式では、これらの解剖学的特徴を理解して手術を遂行することが肝要である。すなわち、前面の切離では前面動脈アーケードとその十二指腸枝を温存すること、背側の切離では膵実質の切離を胆管前面までにとどめ、胆管と十二指腸間に切離が及ばないように配慮し、その間を走行する後上膵十二指腸動脈とその十二指腸枝を損傷しないことが手技上の留意点である。(著者抄録)
  • 山田 智洋, 宮川 秀一, 堀口 明彦, 石原 慎, 伊東 昌広, 浅野 之夫, 古澤 浩一, 山元 俊行, 津田 一樹, 森垣 曉子, 伊藤 良太郎
    日本腹部救急医学会雑誌 31(2) 272-272 2011年2月  
  • 古澤 浩一, 堀口 明彦, 石原 慎, 伊東 昌広, 浅野 之夫, 山元 俊行, 津田 一樹, 伊藤 良太郎, 森垣 暁子, 山田 智洋, 宮川 秀一
    日本腹部救急医学会雑誌 31(2) 397-397 2011年2月  
  • 伊東昌広, 堀口明彦, 宮川秀一
    膵空腸吻合の工夫とそのドレーン管理手術 65(2) 195-198 2011年2月  
  • 宮川秀一, 堀口明彦, 石原慎, 伊東昌広, 浅野之夫, 古澤浩一, 清水朋宏, 山元俊行, 津田一樹, 森垣曉子, 伊藤良太郎, 山田智洋
    外科治療 104(2) 177-181 2011年2月  
  • 石原 慎, 堀口 明彦, 宮川 秀一
    胆道 25(5) 809-814 2011年  
    &lt;b&gt;要旨:&lt;/b&gt;膵・胆管合流異常(以下,合流異常)は,日本膵・胆管合流異常研究会の診断基準で,「解剖学的に膵管と胆管が十二指腸壁外で合流する先天性の奇形をいう.」と定義されている.合流異常には,肝外胆管形態より1)胆管拡張型,2)胆管非拡張型の2つの型がある.胆管拡張型の標準術式は拡張胆管切除,肝管腸吻合術(分流手術)である.術後の合併症として肝内胆管結石形成,遺残膵内胆管結石形成などが問題となっている.胆管非拡張型の場合は,胆嚢を摘出することは合意が得られている.しかし,肝外胆管切除について統一した見解が得られていない.共通管もしくは副膵管の拡張を認める例や複雑な合流形態の例では,膵石(蛋白栓)や膵炎を合併しやすいことから,これらに対する治療について報告されている.&lt;br&gt; 本稿では,先天性胆道拡張症・合流異常に対する治療について概説した.&lt;br&gt;
  • 堀口 明彦, 宇山 一朗, 伊東 昌広, 石原 慎, 浅野 之夫, 宮川 秀一
    胆道 25(4) 645-650 2011年  
    &lt;b&gt;要旨:&lt;/b&gt;腹腔鏡手術は体壁破壊を最小にすることで,患者の術後QOLを大きく向上させた.一方,腹腔鏡手術は手術操作の自由度が低いこと,2次元画像であることが欠点であり,術者のストレスを増大させた.腹腔鏡支援ロボットであるda Vinci Surgical systemの利点は,3次元ハイビジョン,7自由度の関節機能,術者の動きを調整可能なscaling機能,手の震えを除去するfiltering機能,拡大視効果である.これらの機能により,繊細な手術操作もストレスなくできるようになった.しかし,開腹手術と比して手術時間が長いこと,また,通常の腹腔鏡下手術と比べると,da Vinci装着に時間を有することが今後の課題であるが,経験を積み重ね工夫することにより,克服できると考える.胆道領域におけるロボット支援腹腔鏡下手術は近い将来,standardな手技となると思われる.&lt;br&gt;
  • 堀口 明彦, 宇山 一朗, 石田 善敬, 石原 慎, 伊東 昌広, 浅野 之夫, 山元 俊行, 津田 一樹, 森垣 曉子, 伊藤 良太郎, 宮川 秀一
    胆と膵 32(1) 51-55 2011年1月  
    消化器外科領域における腹腔鏡下手術の発展は目覚ましい。近年、ロボット支援による腹腔鏡下手術の報告が散見されるようになった。da Vinci Surgical Systemのメリットは、(1)3次元ハイビジョン映像であり、従来の腹腔鏡と比して安全である。(2)6つの自由度とグリップ機能をもつ高性能な関節機能を有すること。術者の手の動きと鉗子の動きを2:1、3:1、5:1に調整することができるscaling機能と執刀医の手の震えを除去するfiltering機能がついている。また拡大視効果は約15倍まで可能であり、この三つの機能により、膵管空腸粘膜吻合などの詳細な手術操作を必要とするとき、とくに威力を発する。ロボット支援腹腔鏡下膵切除の歴史は浅く、今後、さらに多くの施設でトレーニング、臨床経験を重ねることにより、膵切除術において、きわめて有用な手技になると考える。(著者抄録)
  • 堀口明彦, 宇山一朗, 石田善敬, 石原慎, 伊東昌広, 浅野之夫, 山元俊行, 津田一樹, 森垣曉子, 伊藤良太郎, 宮川秀一
    胆と膵 32(1) 51-55 2011年1月  
  • Akihiko Horiguchi, Shuichi Miyakawa, Shin Ishihara, Masahiro Ito, Yukio Asano, Koichi Furusawa, Tomohiro Shimizu, Toshiyuki Yamamoto
    JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES 17(6) 792-797 2010年11月  
    To apply duodenum-preserving pancreatic head resection (DPPHR) as radical procedure for benign or low-grade malignant tumors, it needs the reconciliation of complete pancreatic head resection and preservation of the bile duct and peripancreatic vessels. Several modifications have been introduced and applied to remove these lesions, however, the techniques have not been made clear in the management of the peripancreatic vessels and the bile duct. The long-term outcomes of the DPPHR have been reported as extremely rare in comparison with pylorus preserving pancreatoduodenectomy (PPPD) in these pancreatic head tumors. The angiograms by multi-detector row CT (MD-CT) can be reconstructed more physiologically than selective angiography. The anterior arcade is predominant in 43% of 64 patients. Therefore, we modified the DPPHR to include a complete resection of the pancreatic head and the preservation of both anterior and posterior arterial arcades. The bile duct is covered by the pancreatic parenchyma in various ways. The techniques of the preservation of the bile duct are also introduced. We performed 21 DPPHRs and 19 PPPDs in the patients with benign or low-grade malignant pancreatic head tumor. There was no significant difference in operative factors. The postoperative death was one patient in PPPD, but none in DPPHR. The postoperative complications of PPPD were more often than that of DPPHR. There is no postoperative recurrence in DPPHR in the follow-up period from 2 to 216 months. Both exocrine and endocrine function and the long-term results following DPPHR were superior to those following PPPD. The DPPHR should be favored over the PPPD in benign or low-grade malignant tumors of the head of the pancreas if there is no compromise with oncologic radicality.
  • 堀口 明彦, 津田 一樹, 宮川 秀一
    日本消化吸収学会総会プログラム・講演抄録集 41回 187-187 2010年10月  
  • 堀口 明彦, 宇山 一朗, 伊東 昌広, 石原 慎, 浅野 之夫, 古澤 浩一, 山元 俊行, 宮川 秀一
    日本臨床外科学会雑誌 71(増刊) 346-346 2010年10月  
  • 浅野 之夫, 堀口 明彦, 石原 慎, 伊東 昌広, 古澤 浩一, 清水 朋宏, 山元 俊行, 津田 一樹, 森垣 曉子, 山田 智洋, 小森 義之, 宮川 秀一
    日本臨床外科学会雑誌 71(増刊) 392-392 2010年10月  
  • 加藤 悠太郎, 杉岡 篤, 所 隆昌, 棚橋 義直, 吉田 淳一, 香川 幹, 竹浦 千夏, 堀口 明彦, 伊東 昌広, 石原 慎, 清水 朋宏, 宮川 秀一
    日本臨床外科学会雑誌 71(増刊) 461-461 2010年10月  
  • 古澤 浩一, 堀口 明彦, 石原 慎, 伊東 昌広, 浅野 之夫, 清水 朋宏, 山元 俊行, 津田 一樹, 森垣 暁子, 山田 智洋, 宮川 秀一
    日本臨床外科学会雑誌 71(増刊) 793-793 2010年10月  
  • 伊東 昌広, 堀口 明彦, 石原 慎, 浅野 之夫, 古澤 浩一, 清水 朋宏, 津田 一樹, 森垣 曉子, 山田 智洋, 宮川 秀一
    日本臨床外科学会雑誌 71(増刊) 843-843 2010年10月  
  • 宇山 一朗, 金谷 誠一郎, 石田 善敬, 花井 恒一, 堀口 明彦, 杉岡 篤, 前田 耕太郎, 宮川 秀一
    日本内視鏡外科学会雑誌 15(7) 175-175 2010年10月  
  • 堀口 明彦, 宇山 一朗, 伊東 昌広, 浅野 之夫, 宮川 秀一
    日本内視鏡外科学会雑誌 15(7) 269-269 2010年10月  
  • 浅野 之夫, 堀口 明彦, 石原 慎, 伊東 昌広, 古澤 浩一, 清水 朋宏, 山元 俊行, 津田 一樹, 森垣 曉子, 山田 智洋, 宮川 秀一
    日本内視鏡外科学会雑誌 15(7) 508-508 2010年10月  
  • 石原 慎, 堀口 明彦, 伊東 昌広, 浅野 之夫, 古澤 浩一, 清水 朋宏, 山元 俊行, 津田 一樹, 森垣 暁子, 伊藤 良太郎, 山田 智洋, 宮川 秀一
    日本膵・胆管合流異常研究会プロシーディングス 33 48-48 2010年9月  
  • 伊東 昌広, 堀口 明彦, 石原 慎, 浅野 之夫, 古澤 浩一, 清水 朋宏, 山元 俊行, 津田 一樹, 森垣 曉子, 山田 智洋, 宮川 秀一
    日本消化器病学会雑誌 107(臨増大会) A971-A971 2010年9月  
  • Masahiro Ito, Yukio Asano, Akihiko Horiguchi, Tomohiro Shimizu, Toshiyuki Yamamoto, Ichiro Uyama, Shuichi Miyakawa
    JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES 17(5) 688-691 2010年9月  
    Introduction Single-incision laparoscopic surgery (SILS) offers the potential advantages of reduced postoperative pain and a lower incidence of port-site complications. Moreover, careful attention to closure can reduce the scarring after surgery. Consequently, this method is a promising technique for reducing postoperative pain, decreasing complications, and improving cosmesis. We have performed cholecystectomy in eight patients by SILS. The umbilicus was the point of entry to the abdomen in all patients. Methods Between May 2009 and October 2009, 31 patients underwent cholecystectomy at our hospital. The umbilicus was the point of entry to the abdomen in all patients. Three SILSs were performed using a new SILS port, and five SILSs were performed by the conventional method in which three ports are inserted into the umbilicus; the remaining ten patients underwent multiple-incision laparoscopic cholecystectomy (standard cholecystectomy). The results for the patients who underwent standard cholecystectomy, conventional SILS, and SILS using the new port were compared using the Mann-Whitney U test. The data are expressed as mean +/- standard deviation. Result Of the eight cholecystectomies carried out, three were performed by SILS using the new port. No complications or mortalities were associated with this technique. The mean operating times for conventional SILS, SILS with the new port, and standard cholecystectomy were 154 +/- 57, 120 +/- 11, and 100 +/- 51 min, respectively; these inter-group differences are not significant. The blood loss in conventional SILS, SILS with the new port, and standard cholecystectomy was 9 +/- 16, 1, and 6.1 +/- 11 g, respectively; these inter-group differences are not significant. All umbilical incisions were concealed within the umbilicus. Conclusion Cholecystectomy performed using SILS with the new port is a safe and feasible approach with reasonable operation times.
  • 石原 慎, 堀口 明彦, 伊東 昌広, 浅野 之夫, 古澤 浩一, 清水 朋宏, 山元 俊行, 津田 一樹, 森垣 曉子, 山田 智洋, 宮川 秀一
    胆道 24(3) 439-439 2010年8月  
  • 山元 俊行, 堀口 明彦, 石原 慎, 伊東 昌広, 浅野 之夫, 古澤 浩一, 清水 朋宏, 津田 一樹, 森垣 曉子, 山田 智洋, 宮川 秀一
    胆道 24(3) 446-446 2010年8月  
  • 伊東 昌広, 堀口 明彦, 石原 慎, 浅野 之夫, 清水 朋宏, 古澤 浩一, 山元 俊行, 津田 一樹, 森垣 曉子, 山田 智洋, 宇山 一朗, 宮川 秀一
    胆道 24(3) 524-524 2010年8月  
  • 古澤 浩一, 堀口 明彦, 石原 慎, 伊東 昌広, 森垣 暁子, 宮川 秀一
    日本救急医学会雑誌 21(8) 552-552 2010年8月  
  • 山田 智洋, 堀口 明彦, 石原 慎, 伊東 昌広, 浅野 之夫, 古澤 浩一, 清水 朋宏, 山元 俊行, 津田 一樹, 森垣 曉子, 宮川 秀一
    肝胆膵治療研究会誌 8(1) 103-103 2010年8月  
  • 浅野 之夫, 堀口 明彦, 石原 慎, 伊東 昌広, 古澤 浩一, 清水 朋宏, 山元 俊行, 津田 一樹, 森垣 曉子, 山田 智洋, 宇山 一朗, 片田 和広, 加藤 良一, 花岡 良太, 赤松 北斗, 宮川 秀一
    肝胆膵治療研究会誌 8(1) 122-122 2010年8月  
  • Akihiko Horiguchi, Shin Ishihara, Masahiro Ito, Nagata Hideo, Yukio Asano, Toshiyuki Yamamoto, Kazuki Tsuda, Satoko Morigaki, Masahiro Shimura, Shuichi Miyakawa
    PANCREAS 39(5) 697-697 2010年7月  
  • 伊東 昌広, 堀口 明彦, 山元 俊行, 宮川 秀一
    日本消化器外科学会総会 65回 527-527 2010年7月  
  • Akihiko Horiguchi, S. Ishihara, M. Ito, Y. Asano, T. Yamamoto, S. Miyakawa
    JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES 17(4) 523-526 2010年7月  
    During a pancreatoduodenectomy (PD) it is important that the anatomy of the arcade of blood vessels in the head of the pancreas is fully understood before the surgery in order to reduce intraoperative bleeding. In most of the patients our group has treated, the inferior pancreaticoduodenal artery (IPDA), one of the efferent arteries of the head of the pancreas, has formed a short common trunk with the first jejunal artery (FJA). Thus, by first locating the origin of the FJA, it was easier to locate the IPDA. There are two ways to locate the IPDA: (1) by measuring the distance between the origin of the superior mesenteric artery (SMA) and that of the FJA; (2) by measuring the distance between the origin of the middle colic artery (MCA) and that of the FJA. Here, we report our measurements of both distances using three-dimensional (3D) models of arteries constructed with multidetector-row computed tomography (MD-CT) images and discuss which is the better measurement to determine the location of the IPDA during PD. A total of 140 patients underwent 64-MD-CT imaging to acquire early and late arterial phase scans. The distance between the origin of the SMA and that of the FJA and the distance between the origin of the MCA and that of the FJA origin were measured. In patients whose IPDA formed either a common trunk with the FJA or arose directly from the SMA, the IPDA or the common truck was located in parallel with the SMA at a very short distance of approximately 18 mm from the MCA origin towards the center. The distance between the SMA origin and the IPDA was significantly longer (approximately 36 mm). Therefore, locating the MCA origin during PD helped determine the location of the IPDA. However, in patients whose anterior inferior pancreaticoduodenal artery (AIPDA) and posterior inferior pancreaticoduodenal artery (PIPDA) arose separately, the distance between the AIPDA origin and the MCA origin was approximately 18 mm, the distance between the AIPDA origin and the PIPDA origin was approximately 19 mm, and the distance between the PIPDA origin and the SMA origin was 19 mm. Thus, locating the SMA helped determine the location of the IPDA during PD in these patients. Based on our findings that the distance between the IPDA origin and the MCA origin was short, we have shown that it is effective to locate the MCA origin in order to determine the location of the IPDA.
  • 堀口明彦, 石原慎, 伊東昌広, 宮川秀一
    胆道 24(2) 245-250 2010年5月31日  
  • 堀口 明彦, 石原 慎, 伊東 昌広, 浅野 之夫, 山元 俊行, 加藤 良一, 花岡 良太, 片田 和広, 宮川 秀一
    消化器外科 33(6) 1041-1048 2010年5月  
  • 堀口 明彦, 宇山 一朗, 石原 慎, 伊東 昌広, 浅野 之夫, 宮川 秀一
    日本外科系連合学会誌 35(3) 379-379 2010年5月  
  • 古澤 浩一, 堀口 明彦, 石原 慎, 伊東 昌広, 浅野 之夫, 清水 朋宏, 山元 俊行, 津田 一樹, 森垣 暁子, 山田 智洋, 宮川 秀一
    日本外科系連合学会誌 35(3) 474-474 2010年5月  
  • 清水 朋宏, 堀口 明彦, 石原 慎, 伊東 昌広, 浅野 之夫, 古澤 浩一, 山元 俊行, 津田 一樹, 森垣 曉子, 山田 智洋, 宮川 秀一
    日本肝胆膵外科学会・学術集会プログラム・抄録集 22回 216-216 2010年5月  
  • 伊東 昌広, 堀口 明彦, 石原 慎, 浅野 之夫, 清水 朋宏, 古澤 浩一, 山元 俊行, 津田 一樹, 森垣 曉子, 山田 智洋, 宇山 一朗, 宮川 秀一
    日本肝胆膵外科学会・学術集会プログラム・抄録集 22回 224-224 2010年5月  
  • 浅野 之夫, 堀口 明彦, 石原 慎, 伊東 昌広, 清水 朋宏, 古澤 浩一, 山元 俊行, 津田 一樹, 森垣 曉子, 山田 智洋, 宮川 秀一
    日本肝胆膵外科学会・学術集会プログラム・抄録集 22回 240-240 2010年5月  
  • 堀口 明彦, 石原 慎, 伊東 昌広, 浅野 之夫, 清水 朋宏, 古澤 浩一, 山元 俊行, 津田 一樹, 森垣 曉子, 山田 智洋, 宮川 秀一
    日本肝胆膵外科学会・学術集会プログラム・抄録集 22回 243-243 2010年5月  

講演・口頭発表等

 448